Meiogenix

Meiogenix and CIRAD signed a collaboration agreement to evaluate the impact of Meiogenix’s SpiX™ technology in modulating meiotic homologous recombination in rice leading to the identification of new varieties of rice with commercial potential.

Meiogenix SAS, a French start-up biotech company developing of a new genomic technology, closed its first round of financing of 1,2M ! from Kurma Biofund, a French venture capital fund focused in Life Sciences.